ABX-0402

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameABX-0402

Drug Alias Nameinflammation nanobodies (Ablynx)nanobody therapeutics (Ablynx)nanobody therapeutic (Ablynx)anti-inflammatory nanobodies (Ablynx)ABX-0402

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionTumor necrosis factor α inhibitors

TargetsTumor necrosis factor α

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAblynx Nv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAblynx Nv

Active IndicationsN/A

Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A